Stephane Corbel
Senior Director Director @Seeking New Opportunities
Signup · Get unlimited contacts
WORK HISTORY
Senior Director Director @Seeking New Opportunities
San Diego, CA, US
Technology Innovation: Spearheaded oncology and technology development with focus on myelodysplastic syndrome, acute myeloid leukemia, and solid tumors using cutting-edge CRISPR platforms combined with clinical diagnostics.Pharmaceutical Industry Experience: Worked across aging, neuroscience, and oncology to develop therapeutics for sarcopenia, cachexia, peripheral neuropathy, and acute myeloid leukemia.Translational Medicine Leadership: Pioneered gene and cell-based therapies for Duchenne Muscular Dystrophy while developing expertise in stem cell reprogramming and muscle biology.Research Interest: Specialized in hematology, immunology, and stem cell biology with focus on blood cell development and disease mechanisms
EDUCATION
The University of British Columbia
Postdoc
Université Paris Cité
Doctor of Philosophy (PhD), Cell/Cellular and Molecular Biology
Université Paris Cité
Bachelor of Science (BS), Cell/Cellular and Molecular Biology
Université Paris Cité
Master's degree, Biology/Biological Sciences
ABOUT STEPHANE CORBEL
With 15+ years advancing therapeutic programs from discovery through clinical development, I specialize in building translational research capabilities that bridge scientific innovation with clinical impact. My experience spans precision oncology startups, global pharmaceutical R&D, and academic translational medicine—providing a unique perspective on accelerating breakthrough therapies to patients.Core Expertise- Therapeutic Areas: Precision oncology • Hematologic malignancies • Duchenne Muscular Dystrophy • Neuromuscular diseases • Immunology (T cell biology, immune trafficking) • Hematology (blood cell development) • Gene & cell therapy • Regenerative medicine- Strategic: Portfolio strategy, translational platform development, biomarker-driven stratification, regulatory strategy, IND-enabling studies- Organizational: Cross-functional team leadership, vendor ecosystem management, clinical partnership development, budget oversight- Technical: Gene therapy (AAV, lentiviral vectors) • Muscle stem cell biology • Immune cell biology • Hematopoietic stem cells • Functional genomics (CRISPR/siRNA) • Translational biomarkers • Disease modeling • Stem cell transplantation Expertise: Oncology, Hematology, Immunology, Adult Stem Cells, Functional Genomics, Neuro-muscular disorders, In Vivo/Ex Vivo Models, Biomarkers, Gene & Cell Therapy Leadership: Program & Portfolio Management | Strategic Vendor Oversight | Regulatory Interface | Scientific Operations | Team Development Looking for: Chief Scientific Officer or VP Translational Medicine opportunities in biotech companies focused on precision oncology, hematologic malignancies, neuromuscular diseases (DMD, myopathies), immunology (T cell therapies, immune cell biology), gene and cell therapy, or regenerative medicine—particularly those building translational platforms from discovery through early clinical development.Let\'s connect if you\'re developing breakthrough therapies in these areas and need strategic R&D leadership.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.